Evidence map›Paper›PMID 27168810›Full record

ArticleExperimental and therapeutic medicine2016

Opioid endocrinopathy: A clinical problem in patients with cancer pain.

Alparslan Merdin, Fatma Avci Merdin, Şeyda Gündüz, Hakan Bozcuk, Hasan Şenol Coşkun

Abstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis.The Journal of clinical endocrinology and metabolism · 2020
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Prevalence of Opioid-Induced Adrenal Insufficiency in Patients Taking Chronic Opioids.The Journal of clinical endocrinology and metabolism · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alparslan MerdinDepartment of Internal Medicine, Akdeniz University Hospital, Antalya 07058, Turkey.
Fatma Avci MerdinDepartment of Internal Medicine, Akdeniz University Hospital, Antalya 07058, Turkey.
Şeyda GündüzDepartment of Medical Oncology, Antalya Education and Research Hospital, Antalya 07070, Turkey.
Hakan BozcukDepartment of Internal Medicine, Division of Oncology, Akdeniz University Hospital, Antalya 07058, Turkey.
Hasan Şenol CoşkunDepartment of Internal Medicine, Division of Oncology, Akdeniz University Hospital, Antalya 07058, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Opioids are commonly used in cancer pain management. The present study aimed to investigate the occurrence of endocrine dysfunction in patients with cancer pain treated with opioids. The study included 20 patients with cancer-associated pain. All data were obtained from malignant tumors diagnosed and followed up at the Oncology Clinic of Akdeniz University Hospital (Akdeniz, Turkey) between May 2009 and December 2013. Serum samples were collected to determine the levels of hypophyseal, gonadal and thyroid hormones. The inclusion criteria for the study were as follows: Chronic cancer pain, daily treatment with a morphine equivalent daily dose (MEDD) of ≥25 mg/dl for ≥1 month, and a visual analog score of <2. All independent predictors were evaluated using logistic regression analysis. The results did not demonstrate any significant association between MEDD and gender, or the levels of adrenocorticotropic hormone, cortisol, prolactin, thyroid-stimulating hormone, free thyroxine, follicle-stimulating hormone and luteinizing hormone. However, the levels of testosterone (P=0.040) and of free testosterone (P=0.041) were significantly affected by the MEDD. Conversely, prolactin levels were demonstrated to significantly increase with MEDD (P=0.083). The results also indicated that the required opioid analgesic dose and MEDD were significantly affected by age (P≤0.001). Opioid therapy in patients with cancer may inhibit gonadal function and cause hyperprolactinemia.

Indexed as

adrenal insufficiencyagecancerendocrinopathyhyperprolactinemiahypogonadismmalignancy-associated painopioid treatment

Identifiers

PMID27168810
PMCPMC4840782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.